Results from the SURPASS Clinical Trial Program The SURPASS program demonstrated remarkable results for tirzepatide
Semaglutide and Diarrhoea: Causes, Symptoms, and How to Manage Semaglutide diarrhoea is a common but usually temporary side effect caused by changes in digestion
Also, treatment in patients hospitalized in Iran is based on the administration of remdesivir or favipiravir and it was impossible to investigate the interaction between L-carnitine and these antiviral drugs
For employers that choose to cover Wegovy for weight loss, the decision applies consistently across both dosage forms
Real-world studies, especially those using large datasets such as ours, have the potential to extend findings from clinical trials, providing important additional information about treatment effectiveness in real-world settings

Seek immediate medical attention (call 999 or go to A&E) if you experience: A seizure or convulsion for the first time Loss of consciousness or altered awareness Severe, persistent headache, especially if accompanied by visual changes, confusion, or neck stiffness Signs of severe hypoglycaemia (confusion, difficulty speaking, loss of coordination) Symptoms of severe dehydration (reduced urination, extreme thirst, dizziness, rapid heartbeat) Contact your GP or healthcare provider if you experience: New or worsening headaches that don't respond to simple analgesia Persistent dizziness affecting daily activities Unusual fatigue or weakness Any neurological symptoms that concern you Patients should not discontinue Wegovy without discussing with their healthcare professional, as clinical review is advised when stopping treatment